135 related articles for article (PubMed ID: 12833071)
1. Nanoparticles for the delivery of genes and drugs to human hepatocytes.
Yamada T; Iwasaki Y; Tada H; Iwabuki H; Chuah MK; VandenDriessche T; Fukuda H; Kondo A; Ueda M; Seno M; Tanizawa K; Kuroda S
Nat Biotechnol; 2003 Aug; 21(8):885-90. PubMed ID: 12833071
[TBL] [Abstract][Full Text] [Related]
2. Rise of the nanomachines.
Russell SJ
Nat Biotechnol; 2003 Aug; 21(8):872-3. PubMed ID: 12894200
[No Abstract] [Full Text] [Related]
3. Bio-nanocapsule conjugated with liposomes for in vivo pinpoint delivery of various materials.
Jung J; Matsuzaki T; Tatematsu K; Okajima T; Tanizawa K; Kuroda S
J Control Release; 2008 Mar; 126(3):255-64. PubMed ID: 18207275
[TBL] [Abstract][Full Text] [Related]
4. In vivo protein delivery to human liver-derived cells using hepatitis B virus envelope pre-S region.
Kasuya T; Yamada T; Uyeda A; Matsuzaki T; Okajima T; Tatematsu K; Tanizawa K; Kuroda S
J Biosci Bioeng; 2008 Jul; 106(1):99-102. PubMed ID: 18691539
[TBL] [Abstract][Full Text] [Related]
5. Gene delivery into hepatocytes with the preS/liposome/DNA system.
Wang Z; Yuan Z; Jin L
Biotechnol J; 2008 Oct; 3(9-10):1286-95. PubMed ID: 18830969
[TBL] [Abstract][Full Text] [Related]
6. The specific delivery of proteins to human liver cells by engineered bio-nanocapsules.
Yu D; Amano C; Fukuda T; Yamada T; Kuroda S; Tanizawa K; Kondo A; Ueda M; Yamada H; Tada H; Seno M
FEBS J; 2005 Jul; 272(14):3651-60. PubMed ID: 16008564
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy of liver tumors with human liver-specific nanoparticles.
Iwasaki Y; Ueda M; Yamada T; Kondo A; Seno M; Tanizawa K; Kuroda S; Sakamoto M; Kitajima M
Cancer Gene Ther; 2007 Jan; 14(1):74-81. PubMed ID: 16990844
[TBL] [Abstract][Full Text] [Related]
8. Electroporation and use of hepatitis B virus envelope L proteins as bionanocapsules.
Yamada T; Jung J; Seno M; Kondo A; Ueda M; Tanizawa K; Kuroda S
Cold Spring Harb Protoc; 2012 Jun; 2012(6):702-5. PubMed ID: 22661433
[TBL] [Abstract][Full Text] [Related]
9. Expression of squamous cell carcinoma antigen-1 in liver enhances the uptake of hepatitis B virus envelope-derived bio-nanocapsules in transgenic rats.
Kasuya T; Nomura S; Matsuzaki T; Jung J; Yamada T; Tatematsu K; Okajima T; Tanizawa K; Kuroda S
FEBS J; 2008 Nov; 275(22):5714-24. PubMed ID: 18959756
[TBL] [Abstract][Full Text] [Related]
10. Human liver-specific nanocarrier in a novel mouse xenograft model bearing noncancerous human liver tissue.
Matsuura Y; Yagi H; Matsuda S; Itano O; Aiura K; Kuroda S; Ueda M; Kitagawa Y
Eur Surg Res; 2011; 46(2):65-72. PubMed ID: 21178358
[TBL] [Abstract][Full Text] [Related]
11. Secretory production system of bionanocapsules using a stably transfected insect cell line.
Shishido T; Muraoka M; Ueda M; Seno M; Tanizawa K; Kuroda S; Fukuda H; Kondo A
Appl Microbiol Biotechnol; 2006 Dec; 73(3):505-11. PubMed ID: 16847600
[TBL] [Abstract][Full Text] [Related]
12. Galactosylated chitosan/DNA nanoparticles prepared using water-soluble chitosan as a gene carrier.
Kim TH; Park IK; Nah JW; Choi YJ; Cho CS
Biomaterials; 2004 Aug; 25(17):3783-92. PubMed ID: 15020154
[TBL] [Abstract][Full Text] [Related]
13. A specific drug targeting system based on polyhydroxyalkanoate granule binding protein PhaP fused with targeted cell ligands.
Yao YC; Zhan XY; Zhang J; Zou XH; Wang ZH; Xiong YC; Chen J; Chen GQ
Biomaterials; 2008 Dec; 29(36):4823-30. PubMed ID: 18824258
[TBL] [Abstract][Full Text] [Related]
14. Thyroid hormone (T3)-modification of polyethyleneglycol (PEG)-polyethyleneimine (PEI) graft copolymers for improved gene delivery to hepatocytes.
Rudolph C; Sieverling N; Schillinger U; Lesina E; Plank C; Thünemann AF; Schönberger H; Rosenecker J
Biomaterials; 2007 Apr; 28(10):1900-11. PubMed ID: 17196251
[TBL] [Abstract][Full Text] [Related]
15. Construction of arginine-rich peptide displaying bionanocapsules.
Shishido T; Yonezawa D; Iwata K; Tanaka T; Ogino C; Fukuda H; Kondo A
Bioorg Med Chem Lett; 2009 Mar; 19(5):1473-6. PubMed ID: 19200722
[TBL] [Abstract][Full Text] [Related]
16. Galactosylated ternary DNA/polyphosphoramidate nanoparticles mediate high gene transfection efficiency in hepatocytes.
Zhang XQ; Wang XL; Zhang PC; Liu ZL; Zhuo RX; Mao HQ; Leong KW
J Control Release; 2005 Feb; 102(3):749-63. PubMed ID: 15681095
[TBL] [Abstract][Full Text] [Related]
17. IONP-PLL: a novel non-viral vector for efficient gene delivery.
Xiang JJ; Tang JQ; Zhu SG; Nie XM; Lu HB; Shen SR; Li XL; Tang K; Zhou M; Li GY
J Gene Med; 2003 Sep; 5(9):803-17. PubMed ID: 12950071
[TBL] [Abstract][Full Text] [Related]
18. Hybrid of baculovirus and galactosylated PEI for efficient gene carrier.
Kim YK; Choi JY; Jiang HL; Arote R; Jere D; Cho MH; Je YH; Cho CS
Virology; 2009 Apr; 387(1):89-97. PubMed ID: 19272627
[TBL] [Abstract][Full Text] [Related]
19. [Approach to transforming hepatitis B virus as a gene therapeutic vector].
Han JQ; Hu DR; Hu XL; Sun DX; Fan GR; Liu CY; Wu YP
Zhonghua Gan Zang Bing Za Zhi; 2003 Jun; 11(6):344-6. PubMed ID: 12837212
[TBL] [Abstract][Full Text] [Related]
20. Specific targeted binding of herpes simplex virus type 1 to hepatocytes via the human hepatitis B virus preS1 peptide.
Argnani R; Boccafogli L; Marconi PC; Manservigi R
Gene Ther; 2004 Jul; 11(13):1087-98. PubMed ID: 15057264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
